|Day Low/High||311.27 / 317.71|
|52 Wk Low/High||263.30 / 380.76|
It's a very different day of trading for the investor favoring energy stocks compared to those hedging their bets on biotech.
Stocks are mixed on Tuesday afternoon as energy pushes the Dow Jones Industrial Average higher while a biotech selloff weighs on the Nasdaq.
Take advantage of elevated option premiums to gain long exposure to biotech.
DNA sequencing company Illumina (ILMN) plummeted in midday trading Tuesday after reporting disappointing preliminary sales for its third quarter.
We'll review all holdings in light of changing economic and market dynamics.
With such a commanding lead in the sequencing business the stock can't stay down for long.
Cramer also likes Skyworks' better-than-expected earnings pre-announcement but Illumina earnings disappointed Wall Street.
Stocks move back into the red by mid-morning Tuesday as the biotech sector suffers another selloff.
Trade-Ideas LLC identified Illumina (ILMN) as an unusual social activity candidate
Illumina (ILMN) stock is declining after the company issued weaker than expected preliminary revenue guidance for the 2015 third and fourth quarters.
Here are Tuesday's top research calls, including ratings changes at FedEx, Cummins, DuPont, Cisco and more.
Stock futures pull back after Monday's surge as earnings season comes into focus.
Illumina, Inc. (NASDAQ:ILMN) today announced it has expanded the rights of use for the HiSeq X Sequencing System to allow customers to perform whole-genome sequencing of non-human species.
Illumina (ILMN) stock is declining in after-hours trading after the company announced lower than expected fourth quarter guidance.
Trade-Ideas LLC identified Illumina (ILMN) as a post-market laggard candidate
Illumina, Inc. (NASDAQ: ILMN) today announced estimated third quarter revenue of approximately $550 million, a 14% increase compared to $481 million in the third quarter of 2014 and 18% growth on a constant...
Trade-Ideas LLC identified Illumina (ILMN) as a "dead cat bounce" (down big yesterday but up big today) candidate
Trade-Ideas LLC identified Illumina (ILMN) as a weak on high relative volume candidate
Here are Thursday's top research calls, including upgrades for Microsoft and Universal Health and downgrades for Allergan and World Wrestling Entertainment.
Illumina, Inc. (NASDAQ: ILMN) today announced several new additions to BaseSpace—the world's largest and most comprehensive cloud computing environment—with the launch of BaseSpace Professional and Enterprise...
Cramer prefers PPG Industries over Apogee Enterprises and is staying away from New York Mortgage Trust.
Cramer says he's no longer bearish but he's not bullish either. Here are seven things that could make him change his mind.
Stocks with insider trader activity include ILMN, EXPO and BBY
Illumina, Inc. (NASDAQ:ILMN) today announced it has launched TruSight® Tumor 15, a next-generation sequencing (NGS) panel designed to identify sequence variants in 15 genes commonly associated with marketed...
Trade-Ideas LLC identified Illumina (ILMN) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, today announced it has joined the Worldwide Innovative Networking (WIN) Consortium.
TheStreet highlights 3 stocks pushing the drugs industry higher today.
Memorial Sloan Kettering Cancer Center (MSK) and Illumina, Inc. (NASDAQ: ILMN) today announced a collaboration to conduct research studies that are critical to understanding the biology of circulating tumor DNA (ctDNA).
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.